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In oesophageal cancer, as in many other malignancies, lymph node
metastasis is an important prognostic factor (Skinner et al, 1982;
Sugimachi et al, 1986; Siewert and Roder, 1992; Kato et al, 1993;
Baba et al, 1994, 1997; Fahn et al, 1994; Roder et al, 1994;
Nishimaki et al, 1994; Bhansali et al, 1997). Of patients who
undergo curative surgery, 13.6–51% of patients relapse within
5 years (Abe et al, 1990; Fahn et al, 1994; Morita et al, 1994; Law
et al, 1996; Bhansali et al, 1997). Therefore accurate evaluation of
cancer spread is desirable to assess both the risk of recurrence and
the prognosis.
Recent developments in molecular biology have produced new
methods to detect smaller numbers of tumour cells. Many kinds of
molecular markers to detect occult tumour cells are being sought
(Pelkey et al, 1996; Raj et al, 1998). It is still controversial whether
occult metastases found by recent techniques have an impact on
patients’ prognosis or not. As for oesophageal cancer, Izbicki et al
(1997) and Luketich et al (1998) reported that microlymph node
metastasis indicates poor prognosis. On the other hand, Glickman
et al (1999) do not recommend extensive lymph node sectioning
with keratin immunohistochemistry because occult lymph node
metastasis was not an independent poor prognostic feature in their
study.
The squamous cell carcinoma (SCC) antigen has been widely
applied as a serum tumour marker of SCC of the uterine cervix,
oesophagus, head and neck, and non-small-cell lung cancer and
some other organs (Kato, 1992). Recently, Stenman et al (1997)
succeeded in detecting tumour cells in the blood of patients with
cervical SCC by RT-nested PCR for SCC antigen gene mRNA.
In this study, we compared the result of the RT-nested PCR for
the SCC antigen mRNA with that of the pathological and the
immunohistochemical examination for cytokeratins to investigate
the usefulness of the SCC antigen gene mRNA expression as a
marker to detect micrometastases of oesophageal cancer.
MATERIALS AND METHODS
Lymph node and tissue samples
A total of 620 lymph nodes were obtained from 14 patients with
oesophageal carcinoma who underwent oesophagectomy at Kyoto
University Hospital (Table 1). Twelve patients had SCC, one
patient had adenocarcinoma originating from the Barrett’s epithe-
lium and one patient had basaloid squamous carcinoma. Three
pN0 patients were included in this study. Normal and malignant
oesophageal tissues were taken from surgical specimens immedi-
ately after resection and stored in liquid nitrogen until the extrac-
tion of RNA. Each lymph node was serially numbered and then cut
into two pieces. One half of a lymph node was formalin-fixed and
subjected to the routine pathological and immunohistochemical
examination. The other half was snap-frozen in liquid nitrogen and
kept in liquid nitrogen until the extraction of RNA. We used
disposable surgical scalpels to cut lymph nodes to avoid cross-
contamination. As controls, lymph nodes were obtained from
breast cancer, gastric cancer, colon cancer and rectal cancer
patients. Each control node proved to be negative for metastasis by
pathological examination and each primary tumour was confirmed
to be negative for the SCC antigen gene expression by RT-nested
PCR.
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The oesophageal cancer cell line, KYSE 273 (Shimada et al, 1992)
that was established from an oesophageal SCC in our laboratory,
was used in this study. This cell line produces SCC antigen in its
culture medium (Shimada, 1999). Normal peripheral blood
mononucleocytes (PBMN) were harvested from the heparinized
blood of healthy volunteers using Lymphoprep (Nycomed
Pharma, Oslo, Norway) gradient centrifugation according to the
manufacturer’s instructions.
Serial dilution of carcinoma cells
Serial dilution of KYSE 273 cells with normal PBMN was carried
out to confirm the sensitivity of this RT-nested PCR assay. Known
numbers of KYSE 273 cells were added to 1 ´ 107 normal PBMN,
to give a ratio ranging from 1 : 102 to 1 : 107, then total RNA was
extracted.
RNA extraction
Total RNA was extracted from cell lines, PBMN, oesophageal
tissues or lymph nodes using the acid guanidinium
thiocyanate–phenol–chloroform extraction method (Chomczynski
and Sacchi, 1987). Extracted RNA was dissolved in DEPC
(diethylpyrocarbonate)-treated water and subjected to reverse
transcription.
Oligonucleotide primers
Primers were designed from the published sequence of human
SCC antigen cDNA (Suminami, 1991). To avoid false-positive
results caused by genomic DNA contamination, primers were
selected which spanned introns (Figure 1). The outer primers
produce a PCR fragment of 1083 bp. The nested primers produce a
PCR fragment of 261 bp. The quality of RNA and cDNA synthesis
was ascertained by amplification of glyceraldehyde phosphate
dehydrogenase (GAPDH) gene as the internal control. The
primer sequences for GAPDH primers were as follows:
5¢-TGGTATCGTGGAAGGACTCATGAC-3¢ and 5¢-ATGCCAGT-
GAGCTTCCCGTTCAGC-3¢.
RT-nested PCR
Reverse transcription was performed using a First Strand cDNA
Synthesis kit (Pharmacia Biotech, Uppsala, Sweden) according to
the manufacturer’s instructions. The random hexamer was used as
the RT primers. After RT, cDNA corresponding to 1 mg of RNA
was used as the PCR template. The first-round PCR was
performed in 50 ml reaction mix containing 20 mM Tris–HCl
(pH 8.4), 50 mM potassium chloride (KCl), 2.0 mM magnesium
chloride (MgCl2), 1 mM each of the two primers (A and B), 0.2 mM
dNTP and 1 U Taq. polymerase (Gibco-BRL, Grand Island, NY,
USA). After initial heating at 94°C for 5 min, 35 cycles of PCR
were carried out (94°C for 30 s, 50°C for 30 s and 72°C). For the
nested PCR, 3 ml aliquot of the first-round PCR product was used
as the template. The nested PCR was carried out in 50 ml reaction
mix containing 20 mM Tris–HCl (pH 8.4), 50 mM KCl, 1.5 mM
MgCl2, 1 mM each of the two primers (C and D), 0.2 mM dNTP and
1U  Taq. polymerase. After initial heating at 94°C for 5 min, 30
cycles of PCR were carried out (94°C for 30 s, 60°C for 30 s and
72°C). For analysis, 10 ml of reaction product was run on a 2%
agarose gel followed by SYBR green (Molecular Probe, Eugene,
OR, USA) staining. The specificity of the PCR product was
confirmed by restriction enzyme digestion pattern (Eae 1) and
sequencing. The 261 bp RT-nested PCR products generated from
KYSE273 cells were cloned into the pCR II plasmid vector using
the TA cloning system (Invitrogen, Carlsbad, CA, USA) and
sequenced by ALF autosequencer (Pharmacia Biotech). A Gen
Bank-Update new sequences library nucleotide database search
demonstrated that the sequence was specific to the SCCA1.
We took special care to avoid cross-contaminations. For
example, we used filtertips of micropipettes in every procedure;
preparation of PCR reagent and electrophoresis of PCR product
were performed in separate places and a negative control, with no
template cDNA, was run with every PCR to exclude carry-over
contaminations.
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Table 1 Clinicopathological background of 14 patients
No. Age Sex Localization Histological type pT pN pM pTNM Serum
stage SCC (ng ml–1)
1 60 F Ce Mod. pT2 pN1 pM0 2B 2.7
2 58 M Ce Well pT4 pN1 pM0 3 <0.5
3 62 M Ce Poor. pT2 pN1 pM0 2B 2.3
4 53 M Iu Mod. pT3 pN1 pM1a 4A 1.9
5 62 M Im Well pT1 pN0 pM0 1 0.69
6 67 M Im Mod. pT1 pN1 pM0 2B 0.87
7 48 F Im Basaloid pT3 pN1 pM0 3 0.73
8 61 M Ei Mod. pT3 pN1 pM0 3 3.9
9 64 M Ei Well pT3 pN0 pM0 2A 0.77
10 50 M Ei Poor. dif. adeno. ca. pT3 pN1 pM0 3 <0.5
11 50 M Ei Mod. pT2 pN1 pM0 2A <0.5
12 56 M Ei Well pT2 pN1 pM0 2A 15.4
13 66 M Ei Mod. pT2 pN1 pM0 2A 0.84
14 71 M Ei Well pT2 pN0 pM0 2A 3.5
Ce: cervical oesophagus, Iu: upper thoracic oesophagus, Im: middle thoracic oesophagus, Ei: lower thoracic oesophagus, Well: well differentiated squamous
cell carcinoma, Mod.: moderately differentiated squamous cell carcinoma, Poor.: poorly differentiated squamous cell carcinoma, Poor. dif. adeno. ca.: poorly
differentiated adenocarcinoma, Basaloid: basaloid (-squamous) carcinoma.The results of RT-nested PCR were compared with that of patho-
logical and immunohistochemical examination in a blind fashion.
Immunohistochemistry
Paraffin-embedded sections were stained for epithelial cyto-
keratins by the streptavidin–peroxidase method. We used anti-
cytokeratin antibody because the antibody for the SCC antigen is
not commercially available. The antibody, AE1/AE3 (Dako,
Kyoto, Japan), has been used for detection of occult tumour cells
in lymph nodes (Greenson et al, 1994; Jeffers et al, 1994) and is
known to be negative in normal lymph nodes. Sections were
dewaxed, rehydrated and blocked endogenous peroxidase by 0.3%
hydrogen peroxide in methanol for 30 min. Antigens were reacti-
vated by microwave treatment. Cell membrane permeability was
enhanced by 0.2% Triton X in phosphate-buffered saline (PBS) for
20 min. Non-specific antigen was blocked by 10% normal horse
serum for 30 min at room temperature. Monoclonal murine anti-
body for epithelial cytokeratins, AE1/AE3 (Dako, Kyoto, Japan),
in PBS containing 1% bovine serum albumin (BSA) was applied
and sections were incubated 4°C overnight. Slides were washed
6 times in PBS and then incubated with biotinylated horse anti-
mouse antibody for 40 min at room temperature. Biotinylated
second antibody was detected by Vectastain Elite ABC Kit
(Vector Laboratories, Burlingame, CA, USA) according to the
manufacturer’s instructions. The slides were then counterstained
by haematoxylin. A lymph node with metastatic oesophageal SCC
was included in all series as the positive control and a negative
control run by exclusion of the primary antibody. All slides were
evaluated in a blind fashion by two observers and all stained cells
were evaluated by a pathologist. We excluded solitary stained cells
without nuclear atypism and cell clusters that were located
apparently out of the lymph node tissue.
Statistical analysis
Wilcoxon signed-rank test was carried out to examine the differ-
ence among the histological examination, the immunohistochem-
ical examination and the RT-nested PCR.
RESULTS
Sensitivity and specificity
Serial dilution experiments showed that our RT-nested PCR assay
detected ten KYSE273 cells per 107 of PBMN (Figure 2). We did
not detect SCC antigen mRNA expression in 43 of the control
lymph nodes from nine patients even when each PCR cycle was
increased to 40 cycles (data not shown). Any non-specific band
was not detected from RNA templates without RT (Figure 2).
Clinical samples
We detected SCC antigen gene expression in all normal and malig-
nant oesophageal tissues analysed in this study (data not shown).
The result from all patients is shown in Table 2. Pathological
examination, immunohistochemical examination and RT-nested
PCR detected 36, 45 and 65 lymph nodes respectively. Twenty-six
lymph nodes were positive only by RT-nested PCR. There were
six metastases detected by immunohistochemistry but not by
RT-nested PCR. In these six nodes, three were from a basaloid
squamous carcinoma patient, two were from an adenocarcinoma
patient and one node was from a SCC patient. RT-nested PCR
detected significantly more lymph nodes than histological
examination (P < 0.0001 by Wilcoxon signed-rank test) and
immunohistochemical examination (P = 0.0004). The immuno-
histochemical examination either detected statistically more nodes
than the pathological examination (P = 0.0027).
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Position Sequence Product
length
Outer primers
A
B
7
1070
5'GCCCACCTCTGCTTCCTCTA3'
5'GCTTCTGCTCCCTCCTCTGT3'
1083 bp
Inner primers
C
D
470
711
5'GCAAATGCTCCAGAAGAAAG3'
5'CGAGGCAAAATGAAAAGATG3'
261 bp
Figure 1 Schematic representation of the squamous cell carcinoma antigen gene and the position of primers used in reverse transcriptase-nested polymerase
chain reaction. The first PCR was performed using primer A and B, followed by the nested PCR using primers C and D to obtain 1083 base-pair (bp) and
261-bp PCR product respectively. The positions of primers indicate their positions in the SCC antigen cDNA reported by Suminami et al (1991)In 12 squamous cell carcinoma cases, the RT-nested PCR
detected all of pathologically positive nodes and all but one
immunohistochemically positive node (Table 3). Both sensitivity
and specificity of the RT-nested PCR were higher in SCC cases
(98.2% and 99.8% respectively) than those in an adenocarcinoma
case (84.6% and 90.9% respectively).
The influence of detected micrometastases on each patient is
summarized in Table 4 (International Union Against Cancer,
1997). The RT-nested PCR for the SCC mRNA found micrometas-
tases in 13 cases out of 14 cases whereas immunohistochemical
examination detected five cases. In all pN0 patients, only RT-
nested PCR revealed positive nodes near the primary tumour in
each case. In three cases, nos 2, 3 and 14, RT-nested PCR detected
tumour dissemination beyond regional lymph nodes (Figure 3)
(Japanese Society for Esophageal Diseases, 1992). Especially in
case 14, who was pN0 by pathological and immunohistochemical
examinations, RT-nested PCR indicated the spread of cancer cells
toward the para-aortic lymph node via the perigastric lymph node.
In case 10, a poorly differentiated adenocarcinoma, RT-nested
PCR detected eight nodes out of nine pathologically positive
nodes and two more positive nodes that were not detected patho-
logically. In contrast to case 10, in case 7, a basaloid squamous,
RT-nested PCR for SCC antigen gene did not detect any positive
nodes out of 51 dissected nodes.
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Table 2 Comparison of the detection of lymph nodes in all patients
Pathology Immunohistochemistry RT-nested PCR Total
(+ = 36) (+ = 45) (+ = 65) (n = 620)
++ + 3 3
+– + 0
–+ + 6
–– + 2 6
++ – 3
+– – 0
–+ – 3
– – – 549
Table 3 Comparison of the detection of lymph nodes in SCC patients
Pathology Immunohistochemistry RT-nested PCR Total
(+ = 25) (+ = 30) (+ = 54) (n = 536)
++ + 2 5
+– + 0
–+ + 4
–– + 2 5
++ – 0
+– – 0
–+ – 1
– – – 481
1000 bp
500 bp
100 bp
SCC
261 bp
GAPDH
212 bp
MABCDEFGHIM
Figure 2 Sensitivity of the assay. Serial dilution of KYSE273 cells in normal peripheral blood mononucleocytes (PBMN) was performed to confirm the
sensitivity of our assay. Different numbers of KYSE273 cells were added to 107 PBMN and then total RNA was extracted. The RT-nested PCR for SCC antigen
gene constantly detected 10 of KYSE273 cells in 107 of PBMN. Lane M: 100-bp ladder marker; lane A: the sample contained no cDNA; lane B: RNA from KYSE
273 cells without reverse transcription; lane C: 1 KYSE273 cells; lane D: 10 KYSE273 cells; lane E: 102 KYSE273 cells; lane F: 103 KYSE273 cells; lane G: 104
KYSE273 cells; lane H: 105 KYSE273 cells in 107 of PBMN respectively, and lane I: KYSE273 cells. In lane H and I, 1083 bp of PCR product from outer primer
set A and B, 724 bp of PCR product produced between primer A and D and 621 bp of PCR product produced between primer C and B are seenThe pN classification by the RT-nested PCR advanced in three
cases and dropped in a basaloid SCC case. The pM classification
advanced in three cases by the RT-nested PCR. Finally, the pTNM
stage advanced in five cases and dropped in a basaloid SCC case
by the RT-nested PCR.
The average micrometastases were 1.9 nodes a case. There were
four cases that had more micrometastases than the average. We are
prospectively following the impact of micrometastases on the
prognosis.
DISCUSSION
The lymph node metastasis, as well as the depth of penetration
(Skinner et al, 1982), and the surgical curability (Roder et al,
1994), is regarded as an important prognostic factor in
oesophageal cancer (Sugimachi et al, 1986; Siewert and Roder,
1992; Kato et al, 1993; Baba et al, 1994, 1997; Fahn et al, 1994;
Nishimaki et al, 1994; Bhansali et al, 1997). Recent development
of molecular biology makes it possible to detect occult tumour
cells and the influence of occult tumour cells has become evident.
Izbicki et al (1997) revealed the impact of micrometastases for the
prognosis of oesophageal cancer patients by immunohistochem-
istry using epithelial-specific antibody, Ber-EP4. They reported
that Ber-EP4-positive cells in ‘tumour free’ lymph nodes were
independently predictive of significantly reduced relapse-free
survival and overall survival. Luketich et al (1998) used RT-PCR
for carcinoembryonic antigen (CEA) mRNA to detect occult
lymph node metastasis of oesophageal cancer and reported that a
positive RT-PCR with negative histological findings may have
poor prognostic implications. On the other hand, McGuckin et al
(1996) analysed 208 axillary node-negative breast cancer patients
using a combination of limited step-sectioning and immunohisto-
chemical staining (with cytokeratin (MNF.116) and MUC1 (BC2)
antibodies) and, though they found that the presence and
increasing size of occult nodal metastases were significantly asso-
ciated with poorer disease-free survival, occult nodal metastases
did not affect overall survival. Glickman et al (1999) reported that
they did not find any correlation between poorer survival rates and
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Table 4 Influence of the detection of micrometastases
Influence
Number of lymph nodes on the N, M and stage
Pathology/IH/RT-nested PCR/Total Pathology/IH/RT
No. Cervical Mediastinal Perigastric Coeliac and Total pT N M Stage
para-aortic
1 3/3/4/20 0/0/0/0 0/0/0/11 0/0/0/0 3/3/4/31 pT2 1/1/1 0/0/0 2B/2B/2B
2 2/2/2/34 0/0/1/13 0/0/0/2 0/0/0/0 2/2/3/49 pT4 1/1/1 0/0/1 3/3/4
3 4/5/10/31 0/0/2/8 0/0/0/0 0/0/0/0 4/5/12/39 pT2 1/1/1 0/0/1 2B/2B/4
4 3/6/6/27 3/3/4/26 1/1/2/18 0/0/0/0 7/10/12/71 pT3 1/1/1 1a/1a/1a 4A/4A/4A
5 0/0/0/0 0/0/1/7 0/0/0/19 0/0/0/0 0/0/1/26 pT1 0/0/1 0/0/0 1/1/2B
6 0/0/0/0 0/0/0/10 1/2/2/19 0/0/0/4 1/2/2/33 pT1 1/1/1 0/0/0 2B/2B/2B
7 0/0/0/15 2/2/0/14 0/1/0/22 0/0/0/0 2/3/0/51 pT3 1/1/0 0/0/0 3/3/2A
8 0/0/0/0 1/1/1/1 4/4/5/14 0/0/0/0 5/5/6/15 pT3 1/1/1 0/0/0 3/3/3
9 0/0/0/0 0/0/0/11 0/0/1/28 0/0/0/0 0/0/1/39 pT3 0/0/1 0/0/0 2A/2A/3
10 0/0/0/0 4/5/6/11 5/7/5/18 0/0/0/4 9/12/11/33 pT3 1/1/1 0/0/0 3/3/3
11 0/0/0/0 1/1/1/27 0/0/3/32 0/0/0/7 1/1/4/66 pT2 1/1/1 0/0/0 2B/2B/2B
12 0/0/0/0 0/0/0/18 1/1/2/20 0/0/0/0 1/1/2/38 pT2 1/1/1 0/0/0 2B/2B/2B
13 0/0/0/0 0/0/0/29 1/1/2/38 0/0/0/0 1/1/2/67 pT2 1/1/1 0/0/0 2B/2B/2B
14 0/0/0/0 0/0/1/25 0/0/3/31 0/0/1/6 0/0/5/62 pT2 0/0/1 0/0/1a 2A/2A/4A
IH: immunohistochemical examination, RT: RT-nested PCR.
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Figure 3 Representative electrophoresis pattern of case 3. In this case,
pathological examination, immunohistochemical examination (IH) and RT-
nested PCR detected 4, 5 and 12 lymph nodes respectively. Only RT-nested
PCR revealed mediastinal lymph node metastases. The first, ninth and tenth
lanes of C and the third lane of E include two lymph nodes. The first lane of
E includes three lymph nodes. M: 100 bp ladder marker, P: KYSE273, N:
negative control contained no template cDNA, A: superficial cervical lymph
nodes, B: cervical paraoesophageal lymph nodes, C: deep cervical lymph
nodes, D: supraclavicular lymph nodes, E: thoracic paraoesophageal lymph
nodes. These names of lymph nodes are according to the nomenclature of
the Japanese Society for Esophageal Disease (JSED)occult lymph node metastases in 78 of lymph node-negative
oesophageal patients using serial sectioning and immunohisto-
chemistry (anti-cytokeratin antibody; AE1/AE3). Thus it seems
likely that occult lymph node metastasis affects disease-free
survival, but it is still controversial whether it really has an impact
on overall survival. Larger scale and longer period study is desir-
able to clarify this issue.
The SCC antigen was isolated from a metastatic, cervical SCC
(Kato and Torigoe, 1977) and has been widely applied as a serum
tumour marker of SCC (Kato, 1992). On the other hand, it also
exists in normal squamous epithelium (Maruo et al, 1985; Matsuda
et al, 1990). The SCC antigen gene was cloned in 1991 and was
identified to be a member of ovalbumin family of serine protease
inhibitors (Suminami, 1991) and it was revealed to be located on
the locus at 18q21.3 and to contain a tandem array of two genes,
SCCA1 and SCCA2 (Schneider et al, 1995). These two genes are
thought to code for the neutral and acidic forms of the protein
respectively. It is thought that the neutral form of the SCC antigen
exists in both normal and malignant squamous epithelium. On the
other hand, the acidic form is the dominant form of the serum SCC
and it is thought to be secreted by malignant cells. However, the
sensitivity of the serum SCC antigen is 28.6–37% (Mealy et al,
1996; Nakamura et al, 1998; Quillien et al, 1998) in oesophageal
cancer. Therefore the acidic form may not always be produced in
oesophageal cancer cells. We think the SCCA1 gene is suitable for
the RT-PCR target because it already exists in squamous cells.
Our RT-nested PCR for the SCC antigen gene more efficiently
detected micrometastases of oesophageal cancer than the immuno-
histochemical staining for the cytokeratins (AE1/AE3). It is
theoretically possible that the RT-nested PCR overlooks micro-
metastases when small numbers of cancer cells are included exclu-
sively in the other half of the lymph node. The only lymph node
from a SCC case that was negative by RT-nested PCR but positive
by immunohistochemical examination (Table 3) may be the case.
Though this problem may occur equally with each method, 
RT-nested PCR found 25 micrometastases that were not detected
by immunohistochemical examination. Generally, in such cases
where a small number of micrometastatic cells are found, 
RT-nested PCR which can analyse a lymph node en bloc which has
an advantage.
Clinical application of these sensitive but laborious methods is
still a problem. Indeed it is not practical to examine every
dissected lymph node by RT-PCR. In order to use these methods
practically, it may be better to focus some key lymph nodes, for
example, recurrent nerve chain (Malassagne et al, 1997) or peri-
gastric nodes or, as Stenman et al (1997) indicated, these methods
can be applicable to detect circulating tumour cells. These highly
sensitive methods can provide new clues to select patients at risk
or to investigate the way of tumour spread.
We detected SCC antigen gene expression in an adenocarci-
noma case. This means, although sensitivity in adenocarcinoma
seems lower than that in SCC, even adenocarcinomas may express
SCC antigen mRNA in the oesophagus. Though the expression of
the SCC antigen mRNA in adenocarcinomas has not been fully
investigated, some previous reports support our findings. For
example, Ueda et al (1984) reported that the SCC antigen (referred
to as TA-4) was detected in some adenocarcinomas of the uterine
cervix and less frequently in those of the endometrium. Crombach
et al (1989) showed elevated cytosolic SCC antigen protein in
adenocarcinomas of the uterine cervix in comparison with other
gynaecological adenocarcinomas. Takeshima et al (1992) detected
mRNA of SCC antigen in the columnar cells of the cervix but not
in the endometrium. Considering these findings, combined with
our observations, we expect that we can detect occult metastases
of an oesophageal adenocarcinoma using SCC antigen gene
expression. However, because we have experienced only two
cases other than SCCs, further study will be needed for the appli-
cation of SCC antigen gene expression for detecting oesophageal
adenocarcinoma micrometastasis.
On the other hand, in a basaloid squamous carcinoma case, our
RT-nested PCR did not detect any metastases. The primary tumour
of this case had a small amount of SCC; most of the tumour was
basaloid carcinoma cells. The lymph node metastases of this case
exclusively consisted of these basaloid carcinoma cells. This may
be the reason our RT-nested PCR detected SCC antigen expression
in the primary tumour but not in lymph node metastases.
In conclusion, the SCC antigen gene is a useful target to find
occult oesophageal SCC cells. The RT-nested PCR for the SCC
antigen gene seems more sensitive in SCC cases. This unique
characteristic of the SCC antigen gene differs from CEA or cyto-
keratins. As Stenman et al (1997) suggested in cervical cancer
cases, this method will be applicable in other SCCs.
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